Analyst Price Target is $46.00
▲ +5.50% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Zymergen in the last 3 months. The average price target is $46.00, with a high forecast of $55.00 and a low forecast of $40.00. The average price target represents a 5.50% upside from the last price of $43.60.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in Zymergen.
Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.